
    
      Intensive Insulin Therapy and Strict Glycemic Control (80-120 mg/dL) Versus Standard Insulin
      Therapy in Neurosurgical Intensive Care Patients (Subarachnoid Hemorrhage, Traumatic Brain
      Injury, Intracranial Expanding Lesion): Safety, and Efficacy (Mortality, Morbidity, Long Term
      Neurologic Outcome).
    
  